BRPI0114400B8 - uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele - Google Patents

uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele

Info

Publication number
BRPI0114400B8
BRPI0114400B8 BRPI0114400A BR0114400A BRPI0114400B8 BR PI0114400 B8 BRPI0114400 B8 BR PI0114400B8 BR PI0114400 A BRPI0114400 A BR PI0114400A BR 0114400 A BR0114400 A BR 0114400A BR PI0114400 B8 BRPI0114400 B8 BR PI0114400B8
Authority
BR
Brazil
Prior art keywords
skin
balance
lactic acid
acid bacteria
immune system
Prior art date
Application number
BRPI0114400A
Other languages
English (en)
Other versions
BR0114400B1 (pt
BR0114400A (pt
Inventor
Gueniche Audrey
Couzy Francois
Breton Lionel
Baur Markus
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0114400A publication Critical patent/BR0114400A/pt
Publication of BR0114400B1 publication Critical patent/BR0114400B1/pt
Publication of BRPI0114400B8 publication Critical patent/BRPI0114400B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)

Abstract

"uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele". a presente invenção refere-se ao uso de probióticos para a preparação de um veículo para equilibrar a função imunológica da pele. em particular, a presente invenção pertence ao uso de microorganismos probióticos para equilibrar a função imunológica da pele sobcondições de tensão, tal como uma exposição a radiação ultravioleta, especificamente para acentuar a atividade imunológica da pele e reduzir a tendência a desenvolver reações alérgicas sob tais condições.
BRPI0114400A 2000-10-06 2001-10-04 uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele BRPI0114400B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00121865 2000-10-06
EP00121865.0 2000-10-06
PCT/EP2001/011475 WO2002028402A1 (en) 2000-10-06 2001-10-04 Use of probiotic lactic acid bacteria for balancing the skin's immune system

Publications (3)

Publication Number Publication Date
BR0114400A BR0114400A (pt) 2003-08-26
BR0114400B1 BR0114400B1 (pt) 2014-04-01
BRPI0114400B8 true BRPI0114400B8 (pt) 2021-05-25

Family

ID=8170032

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0114400A BRPI0114400B8 (pt) 2000-10-06 2001-10-04 uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele

Country Status (14)

Country Link
US (2) US7547527B2 (pt)
EP (2) EP1593382A1 (pt)
JP (1) JP4510376B2 (pt)
CN (1) CN100553646C (pt)
AR (1) AR033580A1 (pt)
AT (1) ATE490776T1 (pt)
AU (2) AU2058702A (pt)
BR (1) BRPI0114400B8 (pt)
CA (1) CA2424607C (pt)
DE (1) DE60143616D1 (pt)
ES (1) ES2357419T3 (pt)
MX (1) MXPA03002957A (pt)
PT (1) PT1322318E (pt)
WO (1) WO2002028402A1 (pt)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040096604A (ko) * 2002-02-21 2004-11-16 소시에떼 데 프로듀이 네슬레 소시에떼아노님 피부의 광보호용 경구 투여성 조성물
FR2844198A1 (fr) * 2002-09-06 2004-03-12 Oreal Utilisation d'un activeur de protectin pour ameliorer la resistance de la peau, composition contenant de tels activateurs et procede de selection
WO2004069156A2 (en) * 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
EP1759597B1 (en) * 2003-03-13 2009-01-21 Kirin Holdings Kabushiki Kaisha Probiotic composition
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
MXPA06015184A (es) 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
AU2005291098B2 (en) * 2004-10-04 2011-11-24 L'oreal Cosmetic and/or dermatological composition for sensitive skins
EP1683425A1 (en) 2005-01-21 2006-07-26 Compagnie Gervais Danone Use of a fermented milk containing L. Casei for the manufacture of a composition for the prevention or treatment of a delayed-type hypersensitivity reaction
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
BRPI0611493B1 (pt) 2005-05-31 2022-04-05 Alimentary Health Ltd. Lactobacilos probióticos felinos
EP1736537A1 (en) * 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
WO2006137513A1 (ja) * 2005-06-24 2006-12-28 Calpis Co., Ltd. 表皮細胞分化及び角化促進剤、並びに表皮角化促進用機能性飲食品
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
DE602006020903D1 (de) 2005-10-18 2011-05-05 Kao Corp Haustierfutter
EP2095820A4 (en) * 2006-12-26 2012-01-11 Meiji Dairies Corp FERMENTED MILK FOR IMPROVEMENT AND / OR TREATMENT OF THE SKIN AND METHOD OF MANUFACTURING THEREOF
EP2124966B1 (en) 2007-02-01 2015-09-09 IAMS Europe B.V. Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
FR2912916B1 (fr) * 2007-02-26 2009-05-22 Oreal Composition cosmetique ou dermatologique comprenant un milieu de culture cellulaire
FR2912917B1 (fr) * 2007-02-26 2012-05-18 Oreal Milieu conditionne et ses utilisations
KR20100016101A (ko) * 2007-03-30 2010-02-12 산토리 홀딩스 가부시키가이샤 부교감 신경 활동 항진 작용을 갖는 의약 조성물 또는 음식물
JP2009102292A (ja) * 2007-04-27 2009-05-14 Chiba Prefecture ストレス抑制剤
FR2919501B1 (fr) * 2007-08-02 2010-12-31 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2920300B1 (fr) * 2007-09-04 2012-12-28 Oreal Utilisation d'une association hesperidine et microorganisme pour agir sur la fonction barriere de la peau.
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920307B1 (fr) * 2007-09-04 2010-06-04 Oreal Utilisation cosmetique de microorganismes.
WO2009031106A2 (en) * 2007-09-04 2009-03-12 L'oreal Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
FR2938437B1 (fr) 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
BRPI0916690B1 (pt) * 2008-07-29 2022-04-12 L'oreal Uso de uma quantidade eficaz de pelo menos um microorganismo probiótico, composição coméstica e/ou dermatólogica, método coméstico para tratar e/ou prevenir distúrbios estéticos do couro cabeludo em um indivíduo, processo cosmético para prevenir e/ou tratar uma condição de caspa do couro cabeludo, conjunto cosmético, e, uso cosmético de pelo menos uma quantidade eficaz de pelo menos um primeiro e um segundo agente cosmético ativo
FR2945944B1 (fr) * 2009-06-02 2011-07-15 Oreal Procede cosmetique de traitement des etats pelliculaires comprenant l'administration d'un microorganisme probiotique et d'un actif antipelliculaire
FR2938429B1 (fr) * 2008-11-19 2012-05-18 Oreal Utilisation cosmetique de microorganisme(s) pour le traitement des desordres du cuir chevelu
FR2937547B1 (fr) 2008-10-28 2012-11-09 Oreal Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses
FR2937536B1 (fr) * 2008-10-28 2016-07-01 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement du cuir chevelu gras
FR2940908B1 (fr) * 2009-01-12 2012-08-24 Oreal Association cosmetique d'un microorganisme et d'un derive phytosphingosine
FR2942720B1 (fr) * 2009-03-03 2024-01-19 Oreal Utilisation cosmetique d'hesperidine.
FR2942719B1 (fr) * 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
JP5860396B2 (ja) * 2009-05-11 2016-02-16 ネステク ソシエテ アノニム ラクトバチルス・ジョンソニーＬａ１ＮＣＣ５３３（ＣＮＣＭＩ−１２２５）及び免疫障害
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US9210945B2 (en) * 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US9173423B2 (en) 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US20110027417A1 (en) * 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
FR2951377B1 (fr) * 2009-10-21 2012-06-22 Oreal Association d'un lysat de probiotique et d'un derive c-glycoside
FR2953407B1 (fr) * 2009-12-08 2013-06-14 Oreal Microorganismes probiotiques a titre d'actif contre les alterations du microrelief
FR2953408B1 (fr) * 2009-12-08 2013-02-08 Oreal Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau
MX2012007873A (es) * 2010-01-06 2012-07-25 Yakult Honsha Kk Promotor de reparacion del daño de acido desoxirribonucleico para aplicacion oral e inhibidor de la actividad de elastasa para apalicacion oral.
FR2959128B1 (fr) 2010-04-23 2012-07-13 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement des odeurs corporelles
EP2397145A1 (en) * 2010-06-18 2011-12-21 Nestec S.A. L. johnsonii La1, B. longum NCC2705 and immune disorders
JP2010280664A (ja) * 2010-07-02 2010-12-16 Biogaia Ab ラクトバチルス・リューテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ）株を用いる哺乳類における免疫機能の改善方法
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
CA2839524C (en) 2011-06-20 2016-05-17 H.J. Heinz Company Probiotic compositions and methods
CN102335413B (zh) * 2011-08-16 2014-07-09 东北农业大学 一种具抗β-乳球蛋白过敏效果的乳杆菌完整肽聚糖的制备方法、产品及其应用
CN102578416B (zh) * 2012-02-23 2014-06-18 北京大北农科技集团股份有限公司 约氏乳杆菌在制备提高畜禽免疫水平饲料中的应用
AU2013299605A1 (en) 2012-08-07 2015-03-26 TopGeniX, Inc. Topical composition comprising transformed bacteria expressing a compound of interest
FR2999601B1 (fr) 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
FR2999931A1 (fr) 2012-12-21 2014-06-27 Oreal Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2999932B1 (fr) 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
JP2017519823A (ja) 2014-06-17 2017-07-20 トップジェニックス, インク.Topgenix, Inc. Ｕｖ保護用局所製剤
DE202015004868U1 (de) 2014-07-11 2015-12-23 Mary Kay Inc. Topische Hautzusammensetzung und deren Verwendung
MX2017010324A (es) 2015-02-16 2017-12-07 Mars Inc Croqueta entrelazada.
BR112017023059B1 (pt) 2015-04-28 2022-07-05 Mars, Incorporated Processo para preparar um produto de ração úmida esterilizada, produto de ração úmida esterilizada, e seu uso
LT6463B (lt) 2015-12-10 2017-10-10 Uab "Probiosanus" Probiotinių bakterijų (pb) gyvybingumo ir stabilumo padidinimas detergentų turinčiuose asmens higienos ir buities priežiūros produktuose
US20170173138A1 (en) * 2015-12-22 2017-06-22 Nestec Sa Immune health for companion animals
EP3435765A1 (en) 2016-03-31 2019-02-06 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
JP2019510036A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物
US10258567B1 (en) 2016-11-17 2019-04-16 Grace Procurements Llc Vaginal probiotic products and related processes
CN106727263B (zh) * 2016-11-22 2019-10-25 深圳弘睿康生物科技有限公司 皮肤微生态改善制剂及其制备方法
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
EP3585356A4 (en) * 2017-02-27 2020-11-04 Continuum Group LLC SUN SCREEN
SG11201908857QA (en) * 2017-04-11 2019-10-30 Servatus Ltd Methods for the treatment of inflammation and inflammatory conditions
WO2018207020A1 (en) * 2017-05-08 2018-11-15 L'oreal Cold atmospheric plasma treatment with chemical or organic compounds to modify the keratinous substrate microbiota
AU2018378419B2 (en) * 2017-12-06 2025-01-09 Lac2biome S.r.l. Composition based on probiotics and uses thereof
CA3090042A1 (en) * 2018-02-02 2019-08-08 Postbiotica S.R.L. Use of a postbiotic-based composition for the treatment of skin diseases
KR102011240B1 (ko) * 2019-01-31 2019-08-14 에스케이바이오랜드 주식회사 신규한 락토바실러스 파라카제이 skb1192 균주 또는 이를 함유하는 광보호 효능이 있는 조성물 및 그 제품
JP2021095394A (ja) * 2019-12-16 2021-06-24 東洋アルミニウム株式会社 肌改善用外用組成物
CN110973254B (zh) * 2019-12-20 2023-03-14 光明乳业股份有限公司 一种可常温存放的活菌酸奶及其制备方法
TWI750716B (zh) 2020-06-30 2021-12-21 豐華生物科技股份有限公司 皮膚外用組成物及其用於製備改善皮膚疾病及皮膚發炎之組成物的用途
KR102558085B1 (ko) * 2021-09-08 2023-07-24 코스맥스 주식회사 비피도박테리움 애니멀리스 서브스페시스 락티스 균주 및 그의 피부 상태 개선 용도
CN113876935B (zh) * 2021-10-19 2025-11-04 深圳市红瑞生物科技有限公司 一种治疗宠物肠道疾病的组合物及其应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244691B (it) * 1991-01-29 1994-08-08 Sitia Yomo Spa Mousse lattea, suo impiego per preparare dessert e dessert cosi' ottenuti
JPH0517363A (ja) * 1991-07-11 1993-01-26 Yakult Honsha Co Ltd 抗炎症剤及びそれを含有する化粧料
KR950014592B1 (ko) 1991-10-22 1995-12-11 주식회사태평양 화장료용 유산균제재
ATE172245T1 (de) * 1992-07-06 1998-10-15 Nestle Sa Milchbakterien
US5302389A (en) * 1992-08-17 1994-04-12 Board Of Regents, The University Of Texas System Method for treating UV-induced suppression of contact hypersensitivity by administration of T4 endonuclease
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
US5324151A (en) * 1993-03-29 1994-06-28 United Technologies Automotive, Inc. Anti-rotational fastener
FR2705015B1 (fr) * 1993-05-10 1995-08-04 Agronomique Inst Nat Rech Produits du type fromages frais et leur procédé d'obtention.
JPH07194317A (ja) * 1993-12-29 1995-08-01 Nichinichi Seiyaku Kk ペットフード
FR2718752B1 (fr) * 1994-04-15 1996-07-12 World Trust Investment Sa Préparations à base de lactosérum fermenté et leurs utilisations.
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JP3995733B2 (ja) * 1995-07-17 2007-10-24 明治乳業株式会社 免疫賦活組成物
JPH09263539A (ja) * 1996-03-29 1997-10-07 Nichinichi Seiyaku Kk 抗真菌作用を有する皮膚疾患治療剤
JPH09301878A (ja) * 1996-05-13 1997-11-25 Youshindou:Kk 腫瘍増殖抑制剤
FR2750298B1 (fr) * 1996-07-01 1998-09-18 Gefa Composition en poudre pour la preparation d'un aliment a base de yaourt
ATE209447T1 (de) * 1996-09-10 2001-12-15 Nestle Sa Milchsäurebakterien enthaltendes getrocknetes nahrungsmittel
JP4064481B2 (ja) * 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 免疫賦活剤
JPH10139674A (ja) * 1996-11-11 1998-05-26 Yakult Honsha Co Ltd インターロイキン１２産生促進剤
CA2274535A1 (en) 1996-12-24 1998-07-02 Societe Des Produits Nestle S.A. Fermented milk product
PT862863E (pt) * 1997-01-09 2002-04-29 Nestle Sa Produto cerealifero contendo probioticos
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
WO1999017788A1 (en) * 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
US5902743A (en) * 1998-03-20 1999-05-11 Wisconsin Alumni Research Foundation Probiotic bifidobacterium strain
JP2000095697A (ja) * 1998-09-18 2000-04-04 Advance Co Ltd 抗アレルギー剤
US6479051B1 (en) 1998-12-11 2002-11-12 Urex Biotex, Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
DE19909820A1 (de) * 1999-02-22 2000-08-24 Heinz Nuenninghoff Kit zur Zubereitung eines Milch- oder Milchmischproduktes und Milch- oder Milchmischprodukt
FR2789854B1 (fr) * 1999-02-23 2001-05-25 Le Sojami Soc Procede de fabrication d'une preparation glacee a base de laits vegetaux, notamment de soja et produits obtenus
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
JP4388644B2 (ja) * 1999-10-18 2009-12-24 大洋香料株式会社 新規乳酸菌発酵代謝物を含有する化粧料
DE10021384A1 (de) * 2000-05-03 2001-11-15 Hora Reiner Ergänzungsfutter für Haustiere
JP2002037739A (ja) * 2000-07-24 2002-02-06 Mikimoto Pharmaceut Co Ltd 免疫調整剤

Also Published As

Publication number Publication date
US7547527B2 (en) 2009-06-16
EP1322318B1 (en) 2010-12-08
US8377679B2 (en) 2013-02-19
AR033580A1 (es) 2003-12-26
US20040013706A1 (en) 2004-01-22
JP2004510740A (ja) 2004-04-08
DE60143616D1 (de) 2011-01-20
PT1322318E (pt) 2011-03-15
AU2002220587B2 (en) 2006-06-29
AU2058702A (en) 2002-04-15
BR0114400B1 (pt) 2014-04-01
EP1593382A1 (en) 2005-11-09
ES2357419T3 (es) 2011-04-26
CA2424607A1 (en) 2002-04-11
ATE490776T1 (de) 2010-12-15
MXPA03002957A (es) 2005-06-30
BR0114400A (pt) 2003-08-26
JP4510376B2 (ja) 2010-07-21
EP1322318A1 (en) 2003-07-02
CN1468105A (zh) 2004-01-14
CN100553646C (zh) 2009-10-28
WO2002028402A1 (en) 2002-04-11
CA2424607C (en) 2013-01-15
US20100080782A1 (en) 2010-04-01

Similar Documents

Publication Publication Date Title
BR0114400A (pt) Uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele
ATE375094T1 (de) Von menschen oder tieren verwenbare diätetische und/oder pharmazeutische zubereitungen, auf basis von probiotischen mikroorganismen
HK1042051A1 (zh) 包含有催化生物拟态固形物的治疗及预防用药物，以及其制备和使用方法
AR029100A1 (es) Nuevos probioticos para aplicaciones de alimento de mascotas
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
BR0206689A (pt) Combinação de probióticos, e, uso desta
BR0016709A (pt) Agente antiadesão da flora patogênica da pele
BRPI0412845A (pt) herpes-vìrus, uso de um vìrus, composição farmacêutica, e, método de tratamento de um tumor em um indivìduo em necessidade do mesmo
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
EP1114829A3 (en) Alloferons - Immunomodulatory peptides
DK1390049T3 (da) Sammensætninger til behandling af dyresygdomme og -syndromer omfattende transferfaktor
ES2195396T3 (es) Producto y preparacion que incluye bacterias lacticas.
BRPI0512146A (pt) métodos para o tratamento de uma infecção endobrÈnquica em um paciente, e de um paciente com fibrose cìstica, sofrendo de uma infecção endobrÈnquica
DE69532921D1 (de) Angesäuertes nitrit zur verwendung als antimikrobielles mittel
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
WO1998019167A3 (en) Cell stress regulated human mhc class i gene
BR0114105A (pt) Bactérias de acido lático capazes de reduzir uma tendência do indivìduo para desenvolver reações alérgicas
DE60236318D1 (de) Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation
AR023141A1 (es) Medio sintetico para cultivar lactobacillus y bifidobacteria
ATE439851T1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
WO2005042699A3 (en) Modified polypeptides with therapeutic activity and methods of use
DE50014268D1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
DE59611307D1 (de) Nucleinsäure-moleküle codierend proteine, die die adhäsion von neisseria-zellen an humane zellen vermitteln

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/04/2014, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 17/04 (2006.01), A61K 8/99 (2017.01), A61K 35

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/10/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2640 DE 10-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.